Key Findings: 
Type of Study: 
Study Result:  Inconclusive
Research Location(s): 
Year of Pub: 
Cannabinoids Studied: 
Chemotype: 
Terpenes Studied: 
Receptors Studied: 
Ligands Studied: 
DOSING DETAILS   
Study Dosing Objective:  Other
Established Protocol:  Adverse effects
Route of Administration: 
Cannabinoid Ratio:  (CBD)   0    
Dosing Regimen:  CBD 10 mg/kg/day
Starting Dose:  20 mg/kg/day
Titration:  A gradual decrease of the cannabidiol from 20 mg/kg/day (450 mg BID) to 15 mg/kg/day (350 mg BID)
Clinical Relevance:  A case report of a patient on long-term cannabidiol therapy with persistent diarrhea, abdominal pain, weight loss, and esophageal eosinophilia likely due to cannabidiol. Symptoms improved with dose adjustments over 2 weeks.
Adverse Events:  persistent diarrhea, abdominal pain, peripheral eosinophilia, esophageal eosinophilia, and weight loss
Additional Notes:  Dose Titration
Citation: